Arterial Occlusive Diseases Clinical Trial
Official title:
An Open-label, Ascending-dose, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion
The purpose of the trial is to evaluate the safety and efficacy of microplasmin administration in patients with acute peripheral arterial occlusion.
This clinical trial is designed as an open-label, dose-escalating, single-centre trial of weight-adjusted dose regimens of microplasmin administered intra-arterially as an infusion to patients with acute peripheral arterial occlusion. Patients who meet all inclusion criteria and none of the exclusion criteria will be administered study drug for up to 4 hours. Different dose regimens will be evaluated in an ascending-dose fashion; an infusion will be administered for up to 4 hours. ;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03724279 -
Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm
|
N/A | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Not yet recruiting |
NCT02841488 -
Ischemic Pain Control With Analgesic Methods Clinical Trial
|
Phase 3 | |
Completed |
NCT00371371 -
Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
|
Phase 1/Phase 2 | |
Completed |
NCT00209443 -
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
|
Phase 3 | |
Completed |
NCT00174759 -
CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
|
Phase 3 | |
Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
Recruiting |
NCT04089943 -
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
|
N/A | |
Recruiting |
NCT04343209 -
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
|
||
Not yet recruiting |
NCT05930145 -
Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT04142021 -
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
|
||
Completed |
NCT03253692 -
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
|
||
Recruiting |
NCT04624854 -
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
|
Phase 4 | |
Active, not recruiting |
NCT02921230 -
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
|
N/A | |
Recruiting |
NCT02593994 -
IRIS-Onyx Cohort in the IRIS-DES Registry
|
||
Completed |
NCT02008097 -
Clinical Benefits of B-Flow Ultrasound
|
N/A | |
Terminated |
NCT01462721 -
The eSVS® Mesh Randomized Post-Market Study
|
N/A | |
Completed |
NCT00282646 -
Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)
|
Phase 2 | |
Not yet recruiting |
NCT04956523 -
Preliminary Tissue Monitoring During Endovascular Intervention Study
|
||
Recruiting |
NCT05616104 -
FLEX FIRST Registry Research Protocol
|